Daily co-trimoxazole prophylaxis reduces mortality in severely immunosuppressed
Sunday, March 28, 2010 - 17:42
in Health & Medicine
Daily administration of a cheap, widely available, antibiotic (co-trimoxazole) as prophylaxis halves mortality in severely immunosuppressed HIV-infected adults starting treatment in Africa; with benefits continuing for at least 72 weeks. Furthermore, co-trimoxazole prophylaxis also reduces malaria incidence. These are the conclusions of an Article published Online First and in an upcoming issue of The Lancet.
